1 Study Coverage 1.1 Albumin (as Excipient) Product Introduction 1.2 Market by Type 1.2.1 Global Albumin (as Excipient) Market Size Growth Rate by Type 1.4.2 Human Serum Albumin 1.4.3 Recombinant Albumin 1.3 Market by Application 1.3.1 Global Albumin (as Excipient) Market Size Growth Rate by Application 1.3.2 Cell Culture Media 1.3.3 Medical Supplements 1.3.4 Therapeutics 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Albumin (as Excipient) Sales Estimates and Forecasts 2016-2027 2.2 Global Albumin (as Excipient) Revenue Estimates and Forecasts 2016-2027 2.3 Global Albumin (as Excipient) Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Albumin (as Excipient) Regions by Sales 2.4.1 Global Top Albumin (as Excipient) Regions by Sales (2016-2021) 2.4.2 Global Top Albumin (as Excipient) Regions by Sales (2022-2027) 2.5 Global Top Albumin (as Excipient) Regions by Revenue 2.5.1 Global Top Albumin (as Excipient) Regions by Revenue (2016-2021) 2.5.2 Global Top Albumin (as Excipient) Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Albumin (as Excipient) Sales by Manufacturers 3.1.1 Global Top Albumin (as Excipient) Manufacturers by Sales (2016-2021) 3.1.2 Global Top Albumin (as Excipient) Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Albumin (as Excipient) Sales in 2020 3.2 Global Albumin (as Excipient) Revenue by Manufacturers 3.2.1 Global Top Albumin (as Excipient) Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Albumin (as Excipient) Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Albumin (as Excipient) Revenue in 2020 3.3 Global Albumin (as Excipient) Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Albumin (as Excipient) Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Albumin (as Excipient) Sales by Type 4.1.1 Global Albumin (as Excipient) Historical Sales by Type (2016-2021) 4.1.2 Global Albumin (as Excipient) Forecasted Sales by Type (2022-2027) 4.1.3 Global Albumin (as Excipient) Sales Market Share by Type (2016-2027) 4.2 Global Albumin (as Excipient) Revenue by Type 4.2.1 Global Albumin (as Excipient) Historical Revenue by Type (2016-2021) 4.2.2 Global Albumin (as Excipient) Forecasted Revenue by Type (2022-2027) 4.2.3 Global Albumin (as Excipient) Revenue Market Share by Type (2016-2027) 4.3 Global Albumin (as Excipient) Price by Type 4.3.1 Global Albumin (as Excipient) Price by Type (2016-2021) 4.3.2 Global Albumin (as Excipient) Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Albumin (as Excipient) Sales by Application 5.1.1 Global Albumin (as Excipient) Historical Sales by Application (2016-2021) 5.1.2 Global Albumin (as Excipient) Forecasted Sales by Application (2022-2027) 5.1.3 Global Albumin (as Excipient) Sales Market Share by Application (2016-2027) 5.2 Global Albumin (as Excipient) Revenue by Application 5.2.1 Global Albumin (as Excipient) Historical Revenue by Application (2016-2021) 5.2.2 Global Albumin (as Excipient) Forecasted Revenue by Application (2022-2027) 5.2.3 Global Albumin (as Excipient) Revenue Market Share by Application (2016-2027) 5.3 Global Albumin (as Excipient) Price by Application 5.3.1 Global Albumin (as Excipient) Price by Application (2016-2021) 5.3.2 Global Albumin (as Excipient) Price Forecast by Application (2022-2027) 6 North America 6.1 North America Albumin (as Excipient) Market Size by Type 6.1.1 North America Albumin (as Excipient) Sales by Type (2016-2027) 6.1.2 North America Albumin (as Excipient) Revenue by Type (2016-2027) 6.2 North America Albumin (as Excipient) Market Size by Application 6.2.1 North America Albumin (as Excipient) Sales by Application (2016-2027) 6.2.2 North America Albumin (as Excipient) Revenue by Application (2016-2027) 6.3 North America Albumin (as Excipient) Market Size by Country 6.3.1 North America Albumin (as Excipient) Sales by Country (2016-2027) 6.3.2 North America Albumin (as Excipient) Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Albumin (as Excipient) Market Size by Type 7.1.1 Europe Albumin (as Excipient) Sales by Type (2017-2027) 7.1.2 Europe Albumin (as Excipient) Revenue by Type (2017-2027) 7.2 Europe Albumin (as Excipient) Market Size by Application 7.2.1 Europe Albumin (as Excipient) Sales by Application (2017-2027) 7.2.2 Europe Albumin (as Excipient) Revenue by Application (2017-2027) 7.3 Europe Albumin (as Excipient) Market Size by Country 7.3.1 Europe Albumin (as Excipient) Sales by Country (2017-2027) 7.3.2 Europe Albumin (as Excipient) Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Albumin (as Excipient) Market Size by Type 8.1.1 Asia Pacific Albumin (as Excipient) Sales by Type (2018-2027) 8.1.2 Asia Pacific Albumin (as Excipient) Revenue by Type (2018-2027) 8.2 Asia Pacific Albumin (as Excipient) Market Size by Application 8.2.1 Asia Pacific Albumin (as Excipient) Sales by Application (2018-2027) 8.2.2 Asia Pacific Albumin (as Excipient) Revenue by Application (2018-2027) 8.3 Asia Pacific Albumin (as Excipient) Market Size by Region 8.3.1 Asia Pacific Albumin (as Excipient) Sales by Region (2018-2027) 8.3.2 Asia Pacific Albumin (as Excipient) Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Albumin (as Excipient) Market Size by Type 9.1.1 Latin America Albumin (as Excipient) Sales by Type (2019-2027) 9.1.2 Latin America Albumin (as Excipient) Revenue by Type (2019-2027) 9.2 Latin America Albumin (as Excipient) Market Size by Application 9.2.1 Latin America Albumin (as Excipient) Sales by Application (2019-2027) 9.2.2 Latin America Albumin (as Excipient) Revenue by Application (2019-2027) 9.3 Latin America Albumin (as Excipient) Market Size by Country 9.3.1 Latin America Albumin (as Excipient) Sales by Country (2019-2027) 9.3.2 Latin America Albumin (as Excipient) Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Albumin (as Excipient) Market Size by Type 6.1.1 Middle East and Africa Albumin (as Excipient) Sales by Type (2016-2027) 6.1.2 Middle East and Africa Albumin (as Excipient) Revenue by Type (2016-2027) 6.2 Middle East and Africa Albumin (as Excipient) Market Size by Application 6.2.1 Middle East and Africa Albumin (as Excipient) Sales by Application (2016-2027) 6.2.2 Middle East and Africa Albumin (as Excipient) Revenue by Application (2016-2027) 6.3 Middle East and Africa Albumin (as Excipient) Market Size by Country 6.3.1 Middle East and Africa Albumin (as Excipient) Sales by Country (2016-2027) 6.3.2 Middle East and Africa Albumin (as Excipient) Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 CSL 11.1.1 CSL Corporation Information 11.1.2 CSL Overview 11.1.3 CSL Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 CSL Albumin (as Excipient) Product Description 11.1.5 CSL Related Developments 11.2 Grifols 11.2.1 Grifols Corporation Information 11.2.2 Grifols Overview 11.2.3 Grifols Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Grifols Albumin (as Excipient) Product Description 11.2.5 Grifols Related Developments 11.3 Takeda 11.3.1 Takeda Corporation Information 11.3.2 Takeda Overview 11.3.3 Takeda Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Takeda Albumin (as Excipient) Product Description 11.3.5 Takeda Related Developments 11.4 Octapharma 11.4.1 Octapharma Corporation Information 11.4.2 Octapharma Overview 11.4.3 Octapharma Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Octapharma Albumin (as Excipient) Product Description 11.4.5 Octapharma Related Developments 11.5 Hualan Bio 11.5.1 Hualan Bio Corporation Information 11.5.2 Hualan Bio Overview 11.5.3 Hualan Bio Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Hualan Bio Albumin (as Excipient) Product Description 11.5.5 Hualan Bio Related Developments 11.6 CBPO 11.6.1 CBPO Corporation Information 11.6.2 CBPO Overview 11.6.3 CBPO Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 CBPO Albumin (as Excipient) Product Description 11.6.5 CBPO Related Developments 11.7 Shanghai RAAS 11.7.1 Shanghai RAAS Corporation Information 11.7.2 Shanghai RAAS Overview 11.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Shanghai RAAS Albumin (as Excipient) Product Description 11.7.5 Shanghai RAAS Related Developments 11.8 Kedrion 11.8.1 Kedrion Corporation Information 11.8.2 Kedrion Overview 11.8.3 Kedrion Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Kedrion Albumin (as Excipient) Product Description 11.8.5 Kedrion Related Developments 11.9 LFB Group 11.9.1 LFB Group Corporation Information 11.9.2 LFB Group Overview 11.9.3 LFB Group Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 LFB Group Albumin (as Excipient) Product Description 11.9.5 LFB Group Related Developments 11.10 Albumedix 11.10.1 Albumedix Corporation Information 11.10.2 Albumedix Overview 11.10.3 Albumedix Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Albumedix Albumin (as Excipient) Product Description 11.10.5 Albumedix Related Developments 11.1 CSL 11.1.1 CSL Corporation Information 11.1.2 CSL Overview 11.1.3 CSL Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 CSL Albumin (as Excipient) Product Description 11.1.5 CSL Related Developments 11.12 Merck 11.12.1 Merck Corporation Information 11.12.2 Merck Overview 11.12.3 Merck Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 Merck Product Description 11.12.5 Merck Related Developments 11.13 Ventria (InVitria) 11.13.1 Ventria (InVitria) Corporation Information 11.13.2 Ventria (InVitria) Overview 11.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 Ventria (InVitria) Product Description 11.13.5 Ventria (InVitria) Related Developments 11.14 HiMedia 11.14.1 HiMedia Corporation Information 11.14.2 HiMedia Overview 11.14.3 HiMedia Albumin (as Excipient) Sales, Price, Revenue and Gross Margin (2016-2021) 11.14.4 HiMedia Product Description 11.14.5 HiMedia Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Albumin (as Excipient) Value Chain Analysis 12.2 Albumin (as Excipient) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Albumin (as Excipient) Production Mode & Process 12.4 Albumin (as Excipient) Sales and Marketing 12.4.1 Albumin (as Excipient) Sales Channels 12.4.2 Albumin (as Excipient) Distributors 12.5 Albumin (as Excipient) Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Albumin (as Excipient) Industry Trends 13.2 Albumin (as Excipient) Market Drivers 13.3 Albumin (as Excipient) Market Challenges 13.4 Albumin (as Excipient) Market Restraints 14 Key Findings in The Global Albumin (as Excipient) Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Albumin (as Excipient) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Human Serum Albumin Table 3. Major Manufacturers of Recombinant Albumin Table 4. Global Albumin (as Excipient) Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Albumin (as Excipient) Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global Albumin (as Excipient) Sales by Region (2016-2021) & (MT) Table 7. Global Albumin (as Excipient) Sales Market Share by Region (2016-2021) Table 8. Global Albumin (as Excipient) Sales by Region (2016-2021) & (MT) Table 9. Global Albumin (as Excipient) Sales Market Share by Region (2022-2027) Table 10. Global Albumin (as Excipient) Revenue by Region (2016-2021) & (US$ Million) Table 11. Global Albumin (as Excipient) Revenue Market Share by Region (2016-2021) Table 12. Global Albumin (as Excipient) Revenue by Region (2022-2027) & (US$ Million) Table 13. Global Albumin (as Excipient) Revenue Market Share by Region (2022-2027) Table 14. Global Albumin (as Excipient) Sales by Manufacturers (2016-2021) & (MT) Table 15. Global Albumin (as Excipient) Sales Share by Manufacturers (2016-2021) Table 16. Global Albumin (as Excipient) Revenue by Manufacturers (2016-2021) & (US$ Million) Table 17. Global Albumin (as Excipient) Revenue Share by Manufacturers (2016-2021) Table 18. Albumin (as Excipient) Price by Manufacturers 2016-2021 (USD/Kg) Table 19. Global Albumin (as Excipient) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2020) Table 21. Albumin (as Excipient) Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Albumin (as Excipient) Product Offered Table 23. Date of Manufacturers Enter into Albumin (as Excipient) Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Albumin (as Excipient) Sales by Type (2016-2021) & (MT) Table 26. Global Albumin (as Excipient) Sales by Type (2022-2027) & (MT) Table 27. Global Albumin (as Excipient) Sales Share by Type (2016-2021) Table 28. Global Albumin (as Excipient) Sales Share by Type (2022-2027) Table 29. Global Albumin (as Excipient) Revenue by Type (2016-2021) & (US$ Million) Table 30. Global Albumin (as Excipient) Revenue by Type (2022-2027) & (US$ Million) Table 31. Global Albumin (as Excipient) Revenue Share by Type (2016-2021) Table 32. Global Albumin (as Excipient) Revenue Share by Type (2022-2027) Table 33. Albumin (as Excipient) Price by Type (2016-2021) & (USD/Kg) Table 34. Global Albumin (as Excipient) Price Forecast by Type (2022-2027) & (USD/Kg) Table 35. Global Albumin (as Excipient) Sales by Application (2016-2021) & (MT) Table 36. Global Albumin (as Excipient) Sales by Application (2022-2027) & (MT) Table 37. Global Albumin (as Excipient) Sales Share by Application (2016-2021) Table 38. Global Albumin (as Excipient) Sales Share by Application (2022-2027) Table 39. Global Albumin (as Excipient) Revenue by Application (2016-2021) & (US$ Million) Table 40. Global Albumin (as Excipient) Revenue by Application (2022-2027) & (US$ Million) Table 41. Global Albumin (as Excipient) Revenue Share by Application (2016-2021) Table 42. Global Albumin (as Excipient) Revenue Share by Application (2022-2027) Table 43. Albumin (as Excipient) Price by Application (2016-2021) & (USD/Kg) Table 44. Global Albumin (as Excipient) Price Forecast by Application (2022-2027) & (USD/Kg) Table 45. North America Albumin (as Excipient) Sales by Type (2016-2021) & (MT) Table 46. North America Albumin (as Excipient) Sales by Type (2022-2027) & (MT) Table 47. North America Albumin (as Excipient) Revenue by Type (2016-2021) & (US$ Million) Table 48. North America Albumin (as Excipient) Revenue by Type (2022-2027) & (US$ Million) Table 49. North America Albumin (as Excipient) Sales by Application (2016-2021) & (MT) Table 50. North America Albumin (as Excipient) Sales by Application (2022-2027) & (MT) Table 51. North America Albumin (as Excipient) Revenue by Application (2016-2021) & (US$ Million) Table 52. North America Albumin (as Excipient) Revenue by Application (2022-2027) & (US$ Million) Table 53. North America Albumin (as Excipient) Sales by Country (2016-2021) & (MT) Table 54. North America Albumin (as Excipient) Sales by Country (2022-2027) & (MT) Table 55. North America Albumin (as Excipient) Revenue by Country (2016-2021) & (US$ Million) Table 56. North America Albumin (as Excipient) Revenue by Country (2022-2027) & (US$ Million) Table 57. Europe Albumin (as Excipient) Sales by Type (2016-2021) & (MT) Table 58. Europe Albumin (as Excipient) Sales by Type (2022-2027) & (MT) Table 59. Europe Albumin (as Excipient) Revenue by Type (2016-2021) & (US$ Million) Table 60. Europe Albumin (as Excipient) Revenue by Type (2022-2027) & (US$ Million) Table 61. Europe Albumin (as Excipient) Sales by Application (2016-2021) & (MT) Table 62. Europe Albumin (as Excipient) Sales by Application (2022-2027) & (MT) Table 63. Europe Albumin (as Excipient) Revenue by Application (2016-2021) & (US$ Million) Table 64. Europe Albumin (as Excipient) Revenue by Application (2022-2027) & (US$ Million) Table 65. Europe Albumin (as Excipient) Sales by Country (2016-2021) & (MT) Table 66. Europe Albumin (as Excipient) Sales by Country (2022-2027) & (MT) Table 67. Europe Albumin (as Excipient) Revenue by Country (2016-2021) & (US$ Million) Table 68. Europe Albumin (as Excipient) Revenue by Country (2022-2027) & (US$ Million) Table 69. Asia Pacific Albumin (as Excipient) Sales by Type (2016-2021) & (MT) Table 70. Asia Pacific Albumin (as Excipient) Sales by Type (2022-2027) & (MT) Table 71. Asia Pacific Albumin (as Excipient) Revenue by Type (2016-2021) & (US$ Million) Table 72. Asia Pacific Albumin (as Excipient) Revenue by Type (2022-2027) & (US$ Million) Table 73. Asia Pacific Albumin (as Excipient) Sales by Application (2016-2021) & (MT) Table 74. Asia Pacific Albumin (as Excipient) Sales by Application (2022-2027) & (MT) Table 75. Asia Pacific Albumin (as Excipient) Revenue by Application (2016-2021) & (US$ Million) Table 76. Asia Pacific Albumin (as Excipient) Revenue by Application (2022-2027) & (US$ Million) Table 77. Asia Pacific Albumin (as Excipient) Sales by Region (2016-2021) & (MT) Table 78. Asia Pacific Albumin (as Excipient) Sales by Region (2022-2027) & (MT) Table 79. Asia Pacific Albumin (as Excipient) Revenue by Region (2016-2021) & (US$ Million) Table 80. Asia Pacific Albumin (as Excipient) Revenue by Region (2022-2027) & (US$ Million) Table 81. Latin America Albumin (as Excipient) Sales by Type (2016-2021) & (MT) Table 82. Latin America Albumin (as Excipient) Sales by Type (2022-2027) & (MT) Table 83. Latin America Albumin (as Excipient) Revenue by Type (2016-2021) & (US$ Million) Table 84. Latin America Albumin (as Excipient) Revenue by Type (2022-2027) & (US$ Million) Table 85. Latin America Albumin (as Excipient) Sales by Application (2016-2021) & (MT) Table 86. Latin America Albumin (as Excipient) Sales by Application (2022-2027) & (MT) Table 87. Latin America Albumin (as Excipient) Revenue by Application (2016-2021) & (US$ Million) Table 88. Latin America Albumin (as Excipient) Revenue by Application (2022-2027) & (US$ Million) Table 89. Latin America Albumin (as Excipient) Sales by Country (2016-2021) & (MT) Table 90. Latin America Albumin (as Excipient) Sales by Country (2022-2027) & (MT) Table 91. Latin America Albumin (as Excipient) Revenue by Country (2016-2021) & (US$ Million) Table 92. Latin America Albumin (as Excipient) Revenue by Country (2022-2027) & (US$ Million) Table 93. Middle East and Africa Albumin (as Excipient) Sales by Type (2016-2021) & (MT) Table 94. Middle East and Africa Albumin (as Excipient) Sales by Type (2022-2027) & (MT) Table 95. Middle East and Africa Albumin (as Excipient) Revenue by Type (2016-2021) & (US$ Million) Table 96. Middle East and Africa Albumin (as Excipient) Revenue by Type (2022-2027) & (US$ Million) Table 97. Middle East and Africa Albumin (as Excipient) Sales by Application (2016-2021) & (MT) Table 98. Middle East and Africa Albumin (as Excipient) Sales by Application (2022-2027) & (MT) Table 99. Middle East and Africa Albumin (as Excipient) Revenue by Application (2016-2021) & (US$ Million) Table 100. Middle East and Africa Albumin (as Excipient) Revenue by Application (2022-2027) & (US$ Million) Table 101. Middle East and Africa Albumin (as Excipient) Sales by Country (2016-2021) & (MT) Table 102. Middle East and Africa Albumin (as Excipient) Sales by Country (2022-2027) & (MT) Table 103. Middle East and Africa Albumin (as Excipient) Revenue by Country (2016-2021) & (US$ Million) Table 104. Middle East and Africa Albumin (as Excipient) Revenue by Country (2022-2027) & (US$ Million) Table 105. CSL Corporation Information Table 106. CSL Description and Major Businesses Table 107. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 108. CSL Albumin (as Excipient) Product Table 109. CSL Recent Developments Table 110. Grifols Corporation Information Table 111. Grifols Description and Major Businesses Table 112. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 113. Grifols Albumin (as Excipient) Product Table 114. Grifols Recent Developments Table 115. Takeda Corporation Information Table 116. Takeda Description and Major Businesses Table 117. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 118. Takeda Albumin (as Excipient) Product Table 119. Takeda Recent Developments Table 120. Octapharma Corporation Information Table 121. Octapharma Description and Major Businesses Table 122. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 123. Octapharma Albumin (as Excipient) Product Table 124. Octapharma Recent Developments Table 125. Hualan Bio Corporation Information Table 126. Hualan Bio Description and Major Businesses Table 127. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 128. Hualan Bio Albumin (as Excipient) Product Table 129. Hualan Bio Recent Developments Table 130. CBPO Corporation Information Table 131. CBPO Description and Major Businesses Table 132. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 133. CBPO Albumin (as Excipient) Product Table 134. CBPO Recent Developments Table 135. Shanghai RAAS Corporation Information Table 136. Shanghai RAAS Description and Major Businesses Table 137. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 138. Shanghai RAAS Albumin (as Excipient) Product Table 139. Shanghai RAAS Recent Developments Table 140. Kedrion Corporation Information Table 141. Kedrion Description and Major Businesses Table 142. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 143. Kedrion Albumin (as Excipient) Product Table 144. Kedrion Recent Developments Table 145. LFB Group Corporation Information Table 146. LFB Group Description and Major Businesses Table 147. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 148. LFB Group Albumin (as Excipient) Product Table 149. LFB Group Recent Developments Table 150. Albumedix Corporation Information Table 151. Albumedix Description and Major Businesses Table 152. Albumedix Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 153. Albumedix Albumin (as Excipient) Product Table 154. Albumedix Recent Developments Table 155. Biotest Corporation Information Table 156. Biotest Description and Major Businesses Table 157. Biotest Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 158. Biotest Albumin (as Excipient) Product Table 159. Biotest Recent Developments Table 160. Merck Corporation Information Table 161. Merck Description and Major Businesses Table 162. Merck Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 163. Merck Albumin (as Excipient) Product Table 164. Merck Recent Developments Table 165. Ventria (InVitria) Corporation Information Table 166. Ventria (InVitria) Description and Major Businesses Table 167. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 168. Ventria (InVitria) Albumin (as Excipient) Product Table 169. Ventria (InVitria) Recent Developments Table 170. HiMedia Corporation Information Table 171. HiMedia Description and Major Businesses Table 172. HiMedia Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 173. HiMedia Albumin (as Excipient) Product Table 174. HiMedia Recent Developments Table 175. Key Raw Materials Lists Table 176. Raw Materials Key Suppliers Lists Table 177. Albumin (as Excipient) Distributors List Table 178. Albumin (as Excipient) Customers List Table 179. Albumin (as Excipient) Market Trends Table 180. Albumin (as Excipient) Market Drivers Table 181. Albumin (as Excipient) Market Challenges Table 182. Albumin (as Excipient) Market Restraints Table 183. Research Programs/Design for This Report Table 184. Key Data Information from Secondary Sources Table 185. Key Data Information from Primary Sources List of Figures Figure 1. Albumin (as Excipient) Product Picture Figure 2. Global Albumin (as Excipient) Market Share by Type in 2020 & 2027 Figure 3. Human Serum Albumin Product Picture Figure 4. Recombinant Albumin Product Picture Figure 5. Global Albumin (as Excipient) Sales Market Share by Application in 2020 & 2027 Figure 6. Cell Culture Media Figure 7. Medical Supplements Figure 8. Therapeutics Figure 9. Albumin (as Excipient) Report Years Considered Figure 10. Global Albumin (as Excipient) Sales 2016-2027 (MT) Figure 11. Global Albumin (as Excipient) Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Albumin (as Excipient) Revenue 2016-2027 (US$ Million) Figure 13. Global Albumin (as Excipient) Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 14. Global Albumin (as Excipient) Sales Market Share by Region (2016-2021) Figure 15. Global Albumin (as Excipient) Sales Market Share by Region (2022-2027) Figure 16. North America Albumin (as Excipient) Sales YoY (2016-2027) & (MT) Figure 17. North America Albumin (as Excipient) Revenue YoY (2016-2027) & (US$ Million) Figure 18. Europe Albumin (as Excipient) Sales YoY (2016-2027) & (MT) Figure 19. Europe Albumin (as Excipient) Revenue YoY (2016-2027) & (US$ Million) Figure 20. Asia-Pacific Albumin (as Excipient) Sales YoY (2016-2027) & (MT) Figure 21. Asia-Pacific Albumin (as Excipient) Revenue YoY (2016-2027) & (US$ Million) Figure 22. Latin America Albumin (as Excipient) Sales YoY (2016-2027) & (MT) Figure 23. Latin America Albumin (as Excipient) Revenue YoY (2016-2027) & (US$ Million) Figure 24. Middle East & Africa Albumin (as Excipient) Sales YoY (2016-2027) & (MT) Figure 25. Middle East & Africa Albumin (as Excipient) Revenue YoY (2016-2027) & (US$ Million) Figure 26. The Top 10 and Top 5 Players Market Share by Albumin (as Excipient) Sales in 2020 Figure 27. The Top 10 and Top 5 Players Market Share by Albumin (as Excipient) Revenue in 2020 Figure 28. Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Global Albumin (as Excipient) Sales Market Share by Type (2016-2027) Figure 30. Global Albumin (as Excipient) Revenue Market Share by Type (2016-2027) Figure 31. Global Albumin (as Excipient) Sales Market Share by Application (2016-2027) Figure 32. Global Albumin (as Excipient) Revenue Market Share by Application (2016-2027) Figure 33. North America Albumin (as Excipient) Sales Market Share by Type (2016-2027) Figure 34. North America Albumin (as Excipient) Revenue Market Share by Type (2016-2027) Figure 35. North America Albumin (as Excipient) Sales Market Share by Application (2016-2027) Figure 36. North America Albumin (as Excipient) Revenue Market Share by Application (2016-2027) Figure 37. North America Albumin (as Excipient) Sales Share by Country (2016-2027) Figure 38. North America Albumin (as Excipient) Revenue Share by Country (2016-2027) Figure 39. U.S. Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 40. Canada Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 41. Europe Albumin (as Excipient) Sales Market Share by Type (2016-2027) Figure 42. Europe Albumin (as Excipient) Revenue Market Share by Type (2016-2027) Figure 43. Europe Albumin (as Excipient) Sales Market Share by Application (2016-2027) Figure 44. Europe Albumin (as Excipient) Revenue Market Share by Application (2016-2027) Figure 45. Europe Albumin (as Excipient) Sales Share by Country (2016-2027) Figure 46. Europe Albumin (as Excipient) Revenue Share by Country (2016-2027) Figure 47. Germany Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 48. France Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 49. U.K. Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 50. Italy Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 51. Russia Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 52. Asia Pacific Albumin (as Excipient) Sales Market Share by Type (2016-2027) Figure 53. Asia Pacific Albumin (as Excipient) Revenue Market Share by Type (2016-2027) Figure 54. Asia Pacific Albumin (as Excipient) Sales Market Share by Application (2016-2027) Figure 55. Asia Pacific Albumin (as Excipient) Revenue Market Share by Application (2016-2027) Figure 56. Asia Pacific Albumin (as Excipient) Sales Share by Region (2016-2027) Figure 57. Asia Pacific Albumin (as Excipient) Revenue Share by Region (2016-2027) Figure 58. China Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 59. Japan Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 60. South Korea Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 61. India Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 62. Australia Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 63. Taiwan Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 64. Indonesia Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 65. Thailand Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 66. Malaysia Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 67. Philippines Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 68. Latin America Albumin (as Excipient) Sales Market Share by Type (2016-2027) Figure 69. Latin America Albumin (as Excipient) Revenue Market Share by Type (2016-2027) Figure 70. Latin America Albumin (as Excipient) Sales Market Share by Application (2016-2027) Figure 71. Latin America Albumin (as Excipient) Revenue Market Share by Application (2016-2027) Figure 72. Latin America Albumin (as Excipient) Sales Share by Country (2016-2027) Figure 73. Latin America Albumin (as Excipient) Revenue Share by Country (2016-2027) Figure 74. Mexico Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 75. Brazil Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 76. Argentina Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 77. Middle East and Africa Albumin (as Excipient) Sales Market Share by Type (2016-2027) Figure 78. Middle East and Africa Albumin (as Excipient) Revenue Market Share by Type (2016-2027) Figure 79. Middle East and Africa Albumin (as Excipient) Sales Market Share by Application (2016-2027) Figure 80. Middle East and Africa Albumin (as Excipient) Revenue Market Share by Application (2016-2027) Figure 81. Middle East and Africa Albumin (as Excipient) Sales Share by Country (2016-2027) Figure 82. Middle East and Africa Albumin (as Excipient) Revenue Share by Country (2016-2027) Figure 83. Turkey Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 84. Saudi Arabia Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 85. U.A.E Albumin (as Excipient) Revenue (2016-2027) & (US$ Million) Figure 86. Albumin (as Excipient) Value Chain Figure 87. Albumin (as Excipient) Production Process Figure 88. Channels of Distribution Figure 89. Distributors Profiles Figure 90. Bottom-up and Top-down Approaches for This Report Figure 91. Data Triangulation Figure 92. Key Executives Interviewed

CSL Grifols Takeda Octapharma Hualan Bio CBPO Shanghai RAAS Kedrion LFB Group Albumedix Biotest Merck Ventria (InVitria) HiMedia